Therefore, GSDMB could serve as a potential indicator for assessing adverse health trajectories in ccRCC patients, potentially playing a pivotal role in the body’s immune response (62, 116). The gene discussed is GSDMB; the disease is nonpapillary renal cell carcinoma.